In a clinical trial of immunization in patients with metastatic melanoma, the expansion and function (tested in vivo and in vitro) of stimulated antigen-specific CD8+ T cells by cancer vaccines were also regulated by increased PD-1 expression (89). The gene discussed is CD8A; the disease is metastatic melanoma.